1 |
中华医学会重症医学分会. 中国重症加强治疗病房患者镇痛和镇静治疗指导意见(2006) [J]. 中华外科杂志, 2006, 44(17): 1158-1166.
|
2 |
Barr J, Fraser GL, Puntillo K, et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit [J]. Crit Care Med, 2013, 41(1): 263-306.
|
3 |
Barr J, Fraser GL, Puntillo K, et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the Intensive Care Unit: executive summary [J]. Am J Health Syst Pharm, 2013, 70(1): 53-8.
|
4 |
Martin J, Heymann A, Bäsell K, et al. Evidence and consensus-based German guidelines for the management of analgesia, sedation and delirium in intensive care--short version [J]. Ger Med Sci, 2010, 8: Doc02.
|
5 |
Shafer A. Complications of sedation with midazolam in the intensive care unit and a comparison with other sedative regimens [J]. Crit Care Med, 1998, 26(5): 947-956.
|
6 |
Smuszkiewicz P, Wiczling P, Przybyłowski K, et al. The pharmacokinetics of propofol in ICUpatients undergoing long-term sedation [J]. Biopharm Drug Dispos, 2016, 37(8): 456-466.
|
7 |
Page VJ, McAuley DF. Sedation/drugs used in intensive care sedation [J]. Curr Opin Anaesthesiol, 2015, 28(2): 139-144.
|
8 |
Sakai EM, Connolly LA, Klauck JA. Inhalation anesthesiology and volatile liquid anesthetics: focus on isoflurane, desflurane, and sevoflurane [J]. Pharmacotherapy, 2005, 25(12): 1773-1788.
|
9 |
Misra S, Koshy T. A review of the practice of sedation with inhalational anaesthetics in the intensive care unit with the AnaConDa(®) device [J]. Indian J Anaesth, 2012, 56(6): 518-523.
|
10 |
Sackey PV, Martling CR, Granath F, et al. Prolonged isoflurane sedation of intensive care unit patients with the Anesthetic Conserving Device [J]. Crit Care Med, 2004, 32(11): 2241-2246.
|
11 |
Mesnil M, Capdevila X, Bringuier S, et al. Long-term sedation in intensive care unit: a randomized comparison between inhaled sevoflurane and intravenous propofol or midazolam [J]. Intensive Care Med, 2011, 37(6): 933-941.
|
12 |
Hellström J, Öwall A, Sackey PV. Wake-up times following sedation with sevoflurane versus propofol after cardiac surgery [J]. Scand Cardiovasc J, 2012, 46(5): 262-268.
|
13 |
Röhm KD, Wolf MW, Schöllhorn T, et al. Short-term sevoflurane sedation using the Anaesthetic Conserving Device after cardiothoracic surgery [J]. Intensive Care Med, 2008, 34(9): 1683-1689.
|
14 |
L′her E, Dy L, Pili R, et al. Feasibility and potential cost/benefit of routine isoflurane sedation using an anesthetic-conserving device: a prospective observational study [J]. Respir Care, 2008, 53(10): 1295-1303.
|
15 |
Bösel J, Purrucker JC, Nowak F, et al. Volatile isoflurane sedation in cerebrovascular intensive care patients using AnaConDa(®): effects on cerebral oxygenation, circulation, and pressure [J]. Intensive Care Med, 2012, 38(12): 1955-1964.
|
16 |
Villa F, Iacca C, Molinari AF, et al. Inhalation versus endovenous sedation in subarachnoid hemorrhage patients: effects on regional cerebral blood flow [J]. Crit Care Med, 2012, 40(10): 2797-2804.
|
17 |
Steurer MP, Steurer MA, Baulig W, et al. Late pharmacologic conditioning with volatile anesthetics after cardiac surgery [J]. Crit Care, 2012, 16(5): R191.
|
18 |
Baron R, Binder A, Biniek R, et al. Evidence and consensus based guideline for the management of delirium, analgesia, and sedation in intensive care medicine. Revision 2015 (DAS-Guideline 2015)-short version [J]. Ger Med Sci, 2015, 13: Doc19.
|
19 |
Geisser W, Schreiber M, Hofbauer H, et al. Sevoflurane versus isoflurane--anaesthesia for lower abdominal surgery. Effects on perioperative glucose metabolism [J]. Acta Anaesthesiol Scand, 2003, 47(2): 174-179.
|